Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Florida Weight Loss MD vs FormBlends

Florida Weight Loss MD
Graded #332

Lower grade

vs+12.600000000000009
FormBlends
Graded #78

Higher grade

The verdict

FormBlends takes it — 72.4/100 to 59.8/100.

FormBlends grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFormBlends +33
50
83
Dose & formulationFormBlends +24
53
77
Clinical oversightFlorida Weight Loss MD +2
78
76
Labs & monitoringFlorida Weight Loss MD +10
62
52
FulfillmentFormBlends +7
67
74
Contract termsFormBlends +8
47
55
Florida Weight Loss MD · left barFormBlends · right bar

The numbers

MetricFlorida Weight Loss MDFormBlends
WeighScore59.8/10072.4/100
GradeCC
Scorecard rank#332#78
SemaglutideNot disclosed$99/mo (compounded)
TirzepatideNot disclosed$349/mo (compounded)
Coverage1 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Florida Weight Loss MD

Graded #332 · C

Strengths

  • Physician-led (Dr. Sergey Terushkin, MD, FACS) with same-day telehealth visits statewide in Florida
  • Offers both compounded GLP-1 and brand Wegovy/Ozempic/Mounjaro/Zepbound when appropriate
  • Accepts most insurance or self-pay; consult $99 with $49 applied to the program

Where it loses points

  • Florida residents only — no service outside the state
  • Monthly medication pricing is not published; disclosed after evaluation
  • Single-clinic operation rather than a national telehealth platform
FormBlends

Graded #78 · C

Strengths

  • Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
  • Physician-supervised program with 24/7 care-team access and free shipping over $150
  • Extensive free educational content, guides and provider comparisons on-site

Where it loses points

  • Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
  • $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
  • State availability and LegitScript status not published; pharmacy is its own FormScripts brand

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard